Progenika Biopharma Lands CE Mark for NGS Familial Hypercholesterolemia Test | GenomeWeb

NEW YORK (GenomeWeb) – Grifols subsidiary Progenika Biopharma today announced it has received the CE mark for its Seqpro Lipo IS next-generation sequencing-based diagnostic assay for familial hypercholesterolemia.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.